Magnetic resonance imaging of breast cancer angiogenesis: A review

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3 SUPPL., 2002, Pages 47-54

  Furman Haran, E ^a   Kelcz, F ^b   Degani, H ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b University of Wisconsin Health   (United States)

Author keywords

Angiogenesis; Breast cancer; Breast MRI; Contrast enhancement; Extracellular volume fraction; Microvessel density; Parametric imaging

Indexed keywords

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; BREAST CANCER; CANCER DIAGNOSIS; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HISTOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; CONTRAST MEDIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0036767226     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Folkman J.: Tumor Angiogenesis. Adv. Cancer Res. 43: 175-203, 1985.
2. Weidner N., Folkman J.: Tumoral vascularity as a prognostic factor in cancer. In: De Vita V. T., Hellman S., Rosenberg S. A., eds.: Important advances in oncology. Philadelphia: Lippincott-Raven, 1996: 11: 167-190.
3. Los M., Voest E. E.: The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer. Semin. Oncol. 28: 93-105, 2001.
4. Ferrara N.: VEGF: an update on biological and therapeutic aspects. Curr. Opin. Biotechnol. 11: 617-624, 2000.
5. Tosetti F., Ferrari N., De Flora S., Albini A.: 'Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents. FASEB 16:2-14, 2002.
6. Jain R. K.: Determinants of tumor blood flow: a review. Cancer Res. 48: 2641-2658, 1988.
7. Shah-Yukich A. A., Nelson A. C.: Characterization of solid tumor microvasculature: a three-dimensional analysis using the polymer casting technique. Lab. Invest. 58: 236-244, 1988.
8. Less J. R., Skalak T. C., Sevick E. M., Jain R. K.: Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res. 51: 265-273, 1991.
9. Zlotecki R. A., Baxter L. T., Boucher Y., Jain R. K.: Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvasc. Res. 50: 429-443, 1995.
10. Jain R. K.: Transport of molecules, particles, and cells in solid tumors. Annual. Rev. Biomed. Eng. 1: 241-263, 1999.
11. Baish J. W., Jain, R. K.: Fractals and cancer. Cancer Res. 60: 3683-3688, 2000.
12. Stohrer M., Boucher Y., Stangassinger M., Jain R. K.: Oncotic pressure in solid tumors is elevated. Cancer Res. 60: 4251-4255, 2000.
13. Woodhouse E. C., Chuaqui R. F., Liotta, L. A.: General mechanisms of metastasis. Cancer 80: 1529-1537, 1997.
14. Ferrara N., Alitalo, K.: Clinical application of angiogenic growth factors and their inhibitors. Nature Med. 5: 1359-1364, 1999.
15. Jain R. K.: Understanding barriers to drug delivery: high resolution in vivo imaging is key. Clin. Cancer Res. 5: 1703-1707, 1999.
16. Weidner N., Folkman J., Pozza F. et al.: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84: 1875-1887, 1992.
17. Horak E. R., Leek R., Klenk N. et al.: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
18. Bosari S., Lee A. K., DeLellis R. A., Wiley B. D., Heatley G. J., Silverman, M. L.: Microvessel quantitation and prognosis in invasive breast carcinoma. Human. Pathol. 23: 755-761, 1992.
19. Toi M., Kashitani J., Tominaga T.: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer 55: 371-374, 1993.
20. Hansen S., Grabau D. A., Sorensen F. B., Bak M., Vach W., Rose C.: The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Cancer Res. 6: 139-146, 2000.
21. Gasparini G., Weidner N., Bevilacqua P. et al.: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol. 12: 454-466, 1994.
22. Fox S., Leek R., Smith K., Hollyer J., Greenall M., Harris A.: Tumor angiogenesis in node-negative breast carcinomas - relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res. Treat. 29: 109-116, 1994.
23. Heimann R., Ferguson D., Powers C., Recant W. M., Weichselbaum R. R., Hellman S.: Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl. Cancer Inst. 88: 1764-1769, 1996.
24. Gasparini G., Toi M., Verderio P., et al.: Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and nodenegative patients. Int. J. Oncol. 12: 1117-1125, 1998.
25. Hall N. R., Fish D. E., Hunt N., Goldin R. D., Guillou P. J., Monson J. R.: Is the relationship between angiogenesis and metastasis in breast cancer real? Surg. Oncol. 1: 223-229, 1992.
26. Hoef M. E. V., Knox W. F., Dhesi S. S., Howell A., Schor A. M.: Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer 29A: 1141-1145, 1993.
27. Axelsson K., Ljung B. M., Moore D. H. 2nd. et al.: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Intl. Cancer Inst. 87: 997-1008, 1995.
28. Costello P., McCann A., Carney D. N., Dervan P. A.: Prognostic significance of microvessel density in lymph node negative breast carcinoma. Human Pathol. 26: 1181-1184, 1995.
29. Siitonen S. M., Haapasalo H. K., Rantala I. S., Helin H. J., Isola J. J.: Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod. Pathol. 8: 745-752, 1995.
30. Morphopoulos G., Pearson M., Ryder W. D., Howell A., Harris M.: Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J. Pathol. 180: 44-49, 1996.
31. Hansen S., Grabau D. A., Rose C., Bak M., Sorensen F. B.: Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab. Invest. 78: 1563-1573, 1998.
32. Vermeulen P. B., Gasparini G., Fox S. B., et al.: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer 32A: 2474-2484, 1996.
33. Ahlgren J., Risberg B., Villman K., Bergh J.: Angiogenesis in invasive breast carcinoma - a prospective study of tumour heterogeneity. Eur. J. Cancer. 38: 64-69, 2002.
34. Zachary I. and Gliki G.: Signaling transducation mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49: 568-581, 2001.
35. Bogin L, Degani H.: Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer. Cancer Res.62:1948-1951, 2002.
36. Degani H., Ronen S. M., Furman-Haran E.: Breast cancer - spectroscopy and imaging of cells and tumors. In: R. J. Gillies ed., NMR in Physiology and Biomedicine. Academic Press, 1994: 329-352.
37. Tofts P. S.: Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imaging. 7: 91-101, 1997.
38. Furman-Haran E., Degani H.: Parametric Analysis of Breast MRI. J. Comput. Assist. Tomogr. 2002 (In press).
39. Heywang S. H., Hahn D., Schmidt H., Krischke I., Eirmann W., Bassermann R., and Lissner J.:MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10: 199-204, 1986.
40. Kaiser W. A., Zeitler E.: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170:681-686, 1989.
41. Nunes L. W., Schnall M. D., Orel S. G., et al.:. Breast MR imaging: interpretation model. Radiology 202: 833-841, 1997.
42. Kuhl C. K.: MRI of breast tumors. Eur. Radiol. 10: 46-58, 2000.
43. Nunes L. W., Schnall M. D., Orel S. G.: Update of breast MR imaging arcitectural interpretation model. Radiology 219: 484-494, 2001.
44. Leach M. O.: Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res. 3: 22-27, 2001.
45. Knopp M. V., Glesel F. L., Marcos H., von Tengg-Kobligk H., Choyke P.: Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top. Magn. Reson. Imaging 12: 301-308, 2001.
46. Padhani A. R., Husband J. E.: Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin. Radiol. 56:607-620, 2001.
47. Kety S. S.: The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev. 3: 1-41, 1951.
48. Patlak C. S., Fenstermacher J. D., Blasberg R. G.: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3: 1-7, 1983.
49. Brix G., Semmler W., Port R., Schad L. R., Layer G., Lorenz W. J.: Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J. Comput. Assist. Tomogr. 15: 621-628, 1991.
50. Larsson H. B. W., Stubgaard M., Frederiksen J. L., Jensen M., Henriksen O., Paulson O. B.: Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn. Reson. Med. 16: 117-131, 1990.
51. Tofts P. S., Kermode A. G.: Measurement of the blood-braion barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn. Reson. Med. 17: 357-367, 1991.
52. Knopp, M. V., Weiss, E., Sinn, H. P., et al.: Pathophysiologic basis of contrast enhanced breast tumors. J. Magn. Reson. Imaging 10: 260-266, 1999.
53. Buckley D. L., Drew P. J., Mussurakis S., Monson J. R. T., Horsman A.: Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J. Magn. Reson. Imaging 7: 461-464, 1997.
54. Hulka C. A., Edmister W. B., Smith B. L., et al.: Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205: 837-842, 1997.
55. Frouge C., Guinebretiere J. M., Contesso G., Paola R. D., Blery M.: Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest. Radiol. 29: 1043-1049, 1994.
56. Buadu L. D., Murakami J., Murayama S., et al.: Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200: 639-649, 1996.
57. Stomper P.C., Winston J. S., Herman S., Klippenstein D. L., Arredondo M. A., Blumenson L. E.: Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res. Treat. 45: 39-46, 1997.
58. Esserman L., Hylton N., George T., Weidner N.: Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J. 5:13-21, 1999.
59. Furman-Haran E., Grobgeld D., Kelcz F., Degani H.: Critical role of spatial resolution in dynamic contrast-enhanced breast MRI. J. Magn. Reson. Imaging 13862-867, 2001.
60. Degani H., Gusis V., Weinstein D., Fields S., Strano S.: Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nature Med. 3: 780-782, 1997.
61. Furman-Haran E., Grobgeld D., Margalit R., Degani H.: Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method. Clin. Cancer Res. 4: 2299-304, 1998
62. Weinstein D., Strano S., Cohen P., Fields S., Gomori J. M., Degani H.: Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging - pilot study. Radiology 210: 233-240, 1999.
63. Furman-Haran E., Margalit R., Grobgeld D., Degani H.: Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. Proc. Natl. Acad. Sci. 93:6247-51, 1996.
64. Furman-Haran E., Grobgeld D., Degani H.: Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors. J. Magn. Reson. 128:161-71, 1997.
65. Kelcz F., Degani H., Grobgeld D., Furman-Haran E.: Clinical testing of the 3TP method for breast MRI diagnosis. In: Proceedings of the Eighth International Society for Magnetic Resonance in Medicine meeting and exhibition, Denver, Colorado, USA, 2000, 3: 2171.
66. Furman-Haran E., Degani H., Kirshenbaum K., and Kelcz F.: A two center clinical testing of the 3TP method for contrast enhanced breast MRI. In: Proceedings of the Ninth International Society for Magnetic Resonance in Medicine meeting and exhibition, Glasgow, Scotland, UK, 2001, 1:566.
67. Daniel B. L., Yen Y., Glover G. H., et al.: Breast Disease: Dynamic Spiral MR Imaging. Radiology 209: 499-509, 1998.
68. Orel S. G., Mendonca M. H., Reynolds C., Schnall M. D., Solin L. J., Sullivan D. C.: MR imaging of ductal carcinoma in situ. Radiology 202: 413-420, 1997.